Home LiteratureArticle Details
PMID: 11596034 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Expression of eukaryotic translation initiation factors 4E and 2alpha is increased frequently in bronchioloalveolar but not in squamous cell carcinomas of the lung.

Cancer ·Vol. 92 ·No. 8 ·2001-10-15 ·Pages 2164-71

Rosenwald IB, Hutzler MJ, Wang S, Savas L, Fraire AE

Abstract

When resting cells are stimulated by growth factors, an increase in protein synthesis follows that depends in part on two key eukaryotic translation initiation factors, 4E and 2alpha (eIF-4E and eIF-2alpha, respectively). In the normal cell, expression and activity of both factors are increased transiently, whereas they become elevated constitutively in oncogene-transformed cultured cells, and overexpression of either initiation factor in rodent cells makes them tumorigenic. In this study, the authors investigated an association between the expression of these translation initiation factors and lung carcinogenesis. The authors analyzed the expression of the protein synthesis initiation factors eIF-4E and eIF-2alpha by immunohistochemistry in bronchioloalveolar (BA) and squamous cell (SC) carcinomas of the lung. Western blot analysis was performed to validate the specificity of antibodies in detecting their cognate proteins. Both eIF-4E and eIF-2alpha were increased frequently in BA carcinomas, whereas only rarely did SC carcinomas demonstrate elevation of these translation initiation factors. An analysis of cyclin D1 expression did not show a strict correlation with the expression of eIF-4E and eIF-2alpha. Increased expression of either one or both translation initiation factors may facilitate accelerated growth and division of neoplastic cells in BA carcinoma of the lung. However, the current findings suggest a possibility that increased cell growth and proliferation in SC carcinoma may be achieved through a mechanism independent of increases in eIF-4E and eIF-2alpha expression.

MeSH Terms
Adenocarcinoma, Bronchiolo-Alveolar/metabolism,pathology Biomarkers, Tumor/metabolism Blotting, Western Carcinoma, Squamous Cell/metabolism,pathology Cyclin D Cyclins/metabolism Eukaryotic Initiation Factor-2/metabolism Eukaryotic Initiation Factor-4E Humans Immunohistochemistry Lung Neoplasms/metabolism,pathology Peptide Initiation Factors/metabolism
Chemicals
Biomarkers, Tumor Cyclin D Cyclins Eukaryotic Initiation Factor-2 Eukaryotic Initiation Factor-4E Peptide Initiation Factors
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Rosenwald I B
Department of Pathology, University of Massachusetts Memorial Health Care, Worcester, Massachusetts, USA. irozenvald@aol.com
Hutzler M J
Wang S
Savas L
Fraire A E
Article Info
Journal
Cancer
Abbr.
Cancer
ISSN
0008-543X
Published
2001-10-15
Pages
2164-71
Language
English
Region
United States
NLM ID
0374236
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com